Clarus Sets June 2020 Virtual Conference Schedule
SALT LAKE CITY, June 08, 2020 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a company focused […]
Concrete Pumping Holdings Sets June 2020 Virtual Conference Schedule
DENVER, June 08, 2020 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (“CPH” or the “Company”), a leading provider […]
ATIF Holdings Limited Announces a One Million Dollar Consulting Service Agreement with Shenzhen Agrecoe Biotechnology Co., Ltd.
Shenzhen, China, June 08, 2020 (GLOBE NEWSWIRE) — ATIF Holdings Limited (NASDAQ: ATIF), a company providing business consulting services and […]
DIGITAL ALLY PRICES $5 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK
Lenexa, KS, June 08, 2020 (GLOBE NEWSWIRE) — Digital Ally, Inc. (DGLY) (the “Company”), which develops, manufactures and markets advanced […]
Ascendis Pharma A/S Announces Participation in ENDO Online 2020
COPENHAGEN, Denmark, June 08, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]
Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement
CHARLESTON, S.C., June 08, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty […]
ShiftPixy to Participate in the Virtual Investor Summit
IRVINE, Calif., June 08, 2020 (GLOBE NEWSWIRE) — ShiftPixy, Inc. (NASDAQ: PIXY), a California-based gig engagement platform provider, today announced […]
Chembio Diagnostics Receives FDA 510(k) Clearance for DPP Zika IgM System
HAUPPAUGE, N.Y., June 08, 2020 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious […]
OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
OTTAWA, June 08, 2020 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection […]
X4 Pharmaceuticals to Host Conference Call and Webcast to Discuss New Phase 2 Clinical Data for Mavorixafor in WHIM Syndrome to be Presented at 25ᵗʰ European Hematology Association Annual Congress
CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development […]
